Numab Therapeutics AG Revenue and Competitors

Wädenswil,

Location

$223M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Numab Therapeutics AG's estimated annual revenue is currently $13M per year.(i)
  • Numab Therapeutics AG's estimated revenue per employee is $155,000
  • Numab Therapeutics AG's total funding is $223M.

Employee Data

  • Numab Therapeutics AG has 84 Employees.(i)
  • Numab Therapeutics AG grew their employee count by -10% last year.

Numab Therapeutics AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Numab Therapeutics AG?

Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCHâ„¢ technology platform we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind. Our lead product was designed to balance potent anti-tumor immunity with a desirable safety profile by targeting 4-1BB, PD-L1 and Human Serum Albumin simultaneously. We believe meeting the highest quality standards in every step of the drug design process matters and will result in better patient outcomes.

keywords:N/A

$223M

Total Funding

84

Number of Employees

$13M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Numab Therapeutics AG News

2022-03-30 - Numab Therapeutics and Ono Pharmaceutical Enter ...

Numab Therapeutics is an oncology-focused biopharmaceutical company based in Zurich-area, Switzerland. At Numab, we are writing the next chapter...